| Product Specs | Description |
|---|
| Manufacturer Name | Novo Nordisk |
| Indications | - Treatment of bleeding episodes and perioperative management in adults and children with hemophilia A or B with inhibitors, congenital Factor VII (FVII) deficiency, and Glanzmann’s thrombasthenia with refractoriness to platelet transfusions, with or without antibodies to platelets.
- Treatment of bleeding episodes and perioperative management in adults with acquired hemophilia
|
| Contraindications | None known |
| Viral Safety Process | Chromatography |
| Product Half-Life | Healthy subjects: 3.54 (0.28) hours |
| Manufacturing Method | Recombinant |
| Storage Requirements/Shelf Life | - Prior to reconstitution, store powder and histidine diluent between 2 – 25°C (36-77°F).
- Do not freeze.
- Store protected from light.
- Do not use past the expiration date.
- After reconstitution, store either at room temperature or refrigerated for up to 3 hours
- Do not freeze reconstituted solution or store in syringes.
|
| Nominal Vial Size & Diluent Volume | 1 mg /1 mL L-histidine in water
2 mg /2 mL L-histidine in water
5 mg /5 mL L-histidine in water
8 mg /8 mL L-histidine in water |
